skip to main content
Idioma:
Refinado por: assunto: Biological And Medical Sciences remover data de publicação: 2009Até2011 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

Palumbo, Antonio ; Bringhen, Sara ; Ludwig, Heinz ; Dimopoulos, Meletios A. ; Bladé, Joan ; Mateos, Maria V. ; Rosiñol, Laura ; Boccadoro, Mario ; Cavo, Michele ; Lokhorst, Henk ; Zweegman, Sonja ; Terpos, Evangelos ; Davies, Faith ; Driessen, Christoph ; Gimsing, Peter ; Gramatzki, Martin ; Hàjek, Roman ; Johnsen, Hans E. ; Leal Da Costa, Fernando ; Sezer, Orhan ; Spencer, Andrew ; Beksac, Meral ; Morgan, Gareth ; Einsele, Hermann ; San Miguel, Jesus F. ; Sonneveld, Pieter

Blood, 2011-10, Vol.118 (17), p.4519-4529 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients

PAIVA, Bruno ; VIDRIALES, Maria-Belén ; PEREZ, Jose J ; MATEO, Gema ; MONTALBAN, Maria Angeles ; MATEOS, Maria Victoria ; BLADE, Joan ; LAHUERTA, Juan José ; ORFAO, Alberto ; SAN MIGUEL, Jesús F

Haematologica (Roma), 2009-11, Vol.94 (11), p.1599-1602 [Periódico revisado por pares]

Pavia: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
3
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
Material Type:
Artigo 		Adicionar ao Meu Espaço

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

KYLE, R. A ; DURIE, B. G. M ; SAN MIGUEL, J ; AVET-LOISEAU, H ; HAJEK, R ; CHEN, W. M ; ANDERSON, K. C ; LUDWIG, H ; SONNEVELD, P ; PAVLOVSKY, S ; PALUMBO, A ; RICHARDSON, P. G ; RAJKUMAR, S. V ; BARLOGIE, B ; GREIPP, P ; VESCIO, R ; TURESSON, I ; WESTIN, J ; BOCCADORO, M ; LANDGREN, O ; BLADE, J ; MERLINI, G ; KRÖGER, N ; EINSELE, H ; VESOLE, D. H ; DIMOPOULOS, M

Leukemia, 2010-06, Vol.24 (6), p.1121-1127 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

DIMOPOULOS, M ; TEMPOS, E ; NIESVIZKY, R ; MOULOPOULOS, L. A ; DURIE, Bgm ; COMENZO, R. L ; TOSI, P ; BEKSAC, M ; SEZER, O ; SIEGE, D ; LOKHORST, H ; KUMAR, S ; RAJKUMAR, S. V

Leukemia, 2009-09, Vol.23 (9), p.1545-1556 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

PALUMBO, A ; SEZER, O ; KUMAR, S ; HAJEK, R ; GIRALT, S ; BRINGHEN, S ; ANDERSON, K. C ; RICHARDSON, P. G ; CAVO, M ; DAVIES, F ; BLADE, J ; EINSELE, H ; KYLE, R ; DIMOPOULOS, M. A ; SPENCER, A ; DISPENZIERI, A ; REIMAN, T ; SHIMIZU, K ; LEE, J. H ; ATTAL, M ; BOCCADORO, M ; MATEOS, M ; CHEN, W ; MIGUEL, J. S ; LUDWIG, H ; JOSHUA, D ; CHIM, J ; HUNGRIA, V ; TURESSON, I ; DURIE, Bgm ; LONIAL, S ; ORLOWSKI, R. Z ; MOREAU, P ; NIESVIZKY, R ; MORGAN, G ; COMENZO, R ; SONNEVELD, P

Leukemia, 2009-10, Vol.23 (10), p.1716-1730 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

MARTINEZ, Esteban ; LARROUSSE, María ; PEREZ, Ignacio ; GATELL, José M ; LLIBRE, Josep M ; GUTIERREZ, Felix ; SAUMOY, Maria ; ANTELA, Antonio ; KNOBEL, Hernando ; MURILLAS, Javier ; BERENGUER, Juan ; PICH, Judit

AIDS (London), 2010-07, Vol.24 (11), p.1697-1707 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
7
Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis
Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

Arribas, Jose R ; Delgado, Rafael ; Arranz, Alberto ; Muñoz, Rosa ; Portilla, Joaquin ; Pasquau, Juan ; Pérez-Elias, María J ; Iribarren, Jose A ; Rubio, Rafael ; Ocampo, Antonio ; Sánchez-Conde, Matilde ; Knobel, Hernando ; Arazo, Piedad ; Sanz, Jesús ; López-Aldeguer, José ; Montes, María L ; Pulido, Federico

Journal of acquired immune deficiency syndromes (1999), 2009-06, Vol.51 (2), p.147-152 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins, Inc

Texto completo disponível

Citações Citado por
8
Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists
Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists

Carmona, Loreto, MD, PhD ; Abasolo, Lydia, MD, PhD ; Descalzo, Miguel A., BSc ; Pérez-Zafrilla, Beatriz, BSc ; Sellas, Agustí, MD ; de Abajo, Francisco, MD, PhD ; Gomez-Reino, Juan J., MD, PhD

Seminars in arthritis and rheumatism, 2011-08, Vol.41 (1), p.71-80 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study

LAHUERTA, Juan José ; MATEOS, Maria Victoria ; CARRERA, Dolores ; BESALDUCH, Joan ; DE ARRIBA, Felipe ; ORIOL, Albert ; ESCODA, Lourdes ; GARCIA-FRADE, Javier ; RIVAS-GONZALEZ, Concepción ; ALEGRE, Adrian ; BLADE, Joan ; SAN MIGUEL, Jesús F ; MARTINEZ-LOPEZ, Joaquin ; GRANDE, Carlos ; DE LA RUBIA, Javier ; ROSINOL, Laura ; SUREDA, Anna ; GARCIA-LARANA, José ; DIAZ-MEDIAVILLA, Joaquín ; HERNANDEZ-GARCIA, Miguel T

Haematologica (Roma), 2010-11, Vol.95 (11), p.1913-1920 [Periódico revisado por pares]

Pavia: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.